M4MM

Grown Rogue Reports Q2 2025 Financial Results

MEDFORD – Grown Rogue International Inc., a flower-focused Cannabis producer known for its craft-driven approach and scaled operations, reported its second quarter 2025 financial results for the period ending June 30, 2025. The company delivered ...

Is This a Meltdown For Michigan Cannabis Market?

LANSING – Michigan's legal Cannabis industry, once a hot spot for progress since recreational legalization in 2018, is now struggling with some serious financial pressures that could threaten its stability. According to a recent report ...

Alberta Leads in Psychedelic-Assisted Therapy Coverage

NEW YORK- Alberta Blue Cross's recent endorsement of insurance coverage for Psychedelic-Assisted Therapy signifies a pioneering move in Canadian healthcare, positioning Alberta as the first province to officially support and regulate such treatments. This development ...

Ontario Anticipates Record Cannabis Revenue

LOS ANGELES- In a landmark financial forecast, Ontario expects to garner over CA$379 million from its share of the federal cannabis duty for the fiscal year April 2024 to March 2025, marking a significant 22.2% ...

Delaware Expands Medical Cannabis Program Access

NEW YORK- Delaware lawmakers have passed a significant bill aimed at broadening access to the state's medical cannabis program. On Thursday, the Delaware Senate approved a proposal that grants healthcare providers the discretion to certify ...

Maryland Awards Social Equity Cannabis Licenses

LOS ANGELES- In a significant move by the Maryland Cannabis Administration, 174 social equity cannabis licenses were awarded through a lottery system, showcasing the state's commitment to diversity and inclusion within the burgeoning cannabis industry. ...

Organigram Announces Investment in Open Book Extracts

NEW YORK- Organigram Holdings, a Canadian cannabis company, announced a $2 million investment in North Carolina-based Open Book Extracts. This move signifies Organigram's entry into the U.S. cannabis market, facilitated by an investment from British ...

Algernon Pharmaceuticals Advances Research Program

LOS ANGELES – In a significant move that underscores its commitment to innovative medical research, Algernon Pharmaceuticals Inc. announced its decision to prioritize its AP-188 ("N,N-Dimethyltryptamine" or "DMT") stroke research program. This announcement follows the ...

Glass House Brands Report Revenue and Profits

LOS ANGELES- In a notable financial turnaround, Glass House Brands, a California-based cannabis producer and retailer, reported significant growth in its fourth-quarter earnings, leading to a record revenue of $160.8 million for the fiscal year ...

Subscribe To Our Newsletter